Koji Ishida
Direktor/Vorstandsmitglied bei Sumitomo Pharma America, Inc.
Aktive Positionen von Koji Ishida
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Koji Ishida
Ehemalige bekannte Positionen von Koji Ishida
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BANK OF JAPAN | Direktor/Vorstandsmitglied | 30.06.2011 | 29.06.2016 |
| SUMITOMO CORPORATION | Direktor/Vorstandsmitglied | 01.06.2017 | - |
| Independent Dir/Board Member | 01.06.2017 | - |
Ausbildung von Koji Ishida
| Graduate School of Economics University of Tokyo | Undergraduate Degree |
Statistik
International
| Japan | 4 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
| Independent Dir/Board Member | 1 |
Sektoral
| Government | 2 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BANK OF JAPAN | Government |
| SUMITOMO CORPORATION | Distribution Services |
| Private Unternehmen | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Börse
- Insiders
- Koji Ishida
- Erfahrung
